| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5604469 | International Journal of Cardiology | 2017 | 8 Pages |
Abstract
Overall, the agents of this class appear to reduce all-cause mortality, cardiovascular mortality, and the incidence of myocardial infarction at mid-term follow up.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matteo Monami, Stefania Zannoni, Laura Pala, Antonio Silverii, Francesco Andreozzi, Giorgio Sesti, Edoardo Mannucci,